Article

5 Essential Handouts and Resources on Cartilage Health and Cartigenix HP®*

Cartilage health is a foundational element of lifelong mobility and comfort.* As individuals increasingly seek simple and proactive ways to support joint function, clinicians need clear, credible resources to guide education, supplement and lifestyle choices, and monitoring. This article highlights five essential practitioner tools—ranging from Calroy Health Sciences’ Joint Health and Mobility Tracker to comparative checklists and research summaries—designed to make cartilage resilience education accessible and actionable for every clinic.

At a Glance: Top 5 Cartigenix HP, Joint Health, and Cartilage Regeneration Resources*†

The following resources help practitioners simplify discussions, reinforce adherence, and empower patients to track and support their own cartilage resilience journey.

Patient-facing education handouts for cartilage preservation*

Patient-centered education is one of the most effective ways to support health, including joint health. When individuals understand the why behind the recommendations you make, they are much more likely to stay motivated and engaged. Calroy’s patient handouts translate detailed scientific information into clear, easy-to-understand language.

For clinics, these handouts can help support a behavioral anchor for consistent engagement. This approach is reinforced by literature showing that structured education enhances adherence and outcomes. Practitioners may offer printable handouts in the clinic, as a digital follow-up resource, or may simply refer individuals to find the resources in this article.

By integrating the five resources linked above—spanning education, monitoring, and scientific evidence—practitioners can build a more informed, collaborative approach to preserving cartilage resilience and lifelong joint vitality.

Comparative Checklist: Cartigenix HP Versus Glucosamine and Chondroitin

Practitioners often face questions about which joint supplements to recommend, and individuals need easy to reference checklists. Most people have heard of glucosamine and chondroitin, because they are commonly recommended supplements and have decades of research. Unfortunately, meta-analyses using glucosamine and chondroitin report no clinically relevant difference vs placebo.

This comparative checklist is a great visual handout for individuals who are looking to quickly assess Cartigenix HP versus glucosamine and chondroitin.

Cartigenix HP, powered by RestorCel, is a next-generation joint support supplement.* It supports cartilage regeneration, joint flexibility, and comfort by targeting the structural foundation of joint health.*†

 

At-a-Glance Cartigenix HP® with RestorCel® Glucosamine & Chondroitin
Human Study Results: Joint comfort Pain scores decreased:*† 

Mixed results: Some studies show modest effect, some show no improvement. 

Meta-analyses report small or no clinically relevant difference vs placebo (Clegg et al., 2006; Wandel et al., 2010; Zhu et al., 2018)

Human Study Results: Mobility and function Daily activity function score:* Increased about 79% (2024) 

6-minute walk test:* Distance increased about 50% (RCT)

Small, inconsistent functional benefit
Human Study Results: Cartilage regeneration In placebo-controlled study on cartilage biomarkers:* (RCT

  • Regeneration markers increased 
  • Degeneration markers decreased
Wandel et al. 2010, BMJ meta-analysis: no effect on joint space narrowing; some small, inconsistent benefits reported in some participants
How Long Does it Take to Notice a Difference? Some changes reported in as little as 15 days; statistically significant by 90 days*† If effective, requires weeks to months
Safety  Generally well tolerated with no adverse effects reported in studies. Speak with your healthcare provider before adding any supplement to your routine. Generally safe; caution with shellfish allergy, anticoagulants, GI upset. Speak with your healthcare provider before adding any supplement to your routine.
Quality and Purity Every bottle is manufactured under Calroy’s Total Quality System, with strict cGMP compliance and rigorous batch testing for identity, purity, and potency. Variable quality/purity
Published Research Available 3 published human studies, including one that was double-blind and placebo controlled (RCT) *† Dozens of randomized controlled trials (RCTs), several large meta-analyses (Wandel et al. BMJ 2010)

This comparison helps practitioners transparently discuss available clinical data and guide personalized supplement recommendations consistent with current research.

†As shown in a placebo-controlled, randomized, controlled human research study (Vaidya 2025) and an observational study (Desai 2024). A prospective study (n=1,236) similarly demonstrated significant improvements in pain scores, along with quality of life measures (Desai 2022).

Joint Health and Mobility Tracker

Supporting cartilage resilience requires measurable progress. Calroy created an easy-to-follow Joint Health and Mobility Tracker to support this. The tracker enables patients to easily monitor comfort, mobility, and function metrics rooted in validated assessments such as the six-minute walk test. This handout can easily be printed at home, and takes less than 10 minutes per week to complete. It is a great way to promote engagement and track progress between visits.

Using this tool:

  • Individuals can record joint comfort, confidence, and function.
  • Practitioners gain objective indicators to assess progress and adherence over time.
  • The tracker minimizes recall bias, helping patients recognize progress as function returns. This is especially important over the course of months, where individuals may not recognize that their new normal is quite different from their past experience.

Published Research on Cartigenix HP with RestorCel

Cartigenix HP has been evaluated in three published human trials, including a randomized, placebo-controlled study. In the studies, participants showed an average 67% reduction in pain scores and a 50% increase in walking distance within 90 days, with measurable cartilage regeneration biomarkers and noticeable improvements as early as 15 days.†

The RestorCel formulation that powers Cartigenix HP is backed by three published human studies:

  • Vaidya 2025 (Randomized, Double-Blind, Placebo-Controlled Trial): 62 adults aged 40-65 over 90 days; demonstrated 64% improvement in WOMAC pain scores, 50% improvement in walking distance, and increased cartilage regeneration biomarkers.*
  • Desai 2024 (Observational Study): 394 adults aged 18 and over for 90 days; showed 75% improvement in WOMAC pain scores and 78% improvement in quality of life scores.*
  • Desai 2022 (Prospective Study): 1,236 adults aged 19-75 over 90 days; reported 72.5% improvement in WOMAC pain scores.*

Practitioners can access summaries and full reports through Calroy’s online Practitioner Education Hub.

Cartigenix HP Product Information Sheet

This handout helps individuals better understand Cartigenix HP at a glance. It is aesthetically pleasing and easy to understand. Individuals appreciate knowing the benefits and science behind the supplements clinicians recommend. The Cartigenix HP product information sheet presents a concise overview of the formula, key ingredients, and the research. Whether printed in clinic or provided digitally, the handout reinforces dosing recommendations, ingredient information, and research.

This resource promotes confidence, continuity, and informed participation in the individual’s joint health plan.

Calroy’s Education Center

At Calroy.com/education-center, practitioners and individuals can expand their understanding of cartilage biology, joint care, and foundational health strategies. The portal offers:

  • Informational resources on the ingredients in Cartigenix HP
  • Easily digestible definitions for key aspects of joint and cartilage health and biology
  • Practical guides for joint health, movement and cartilage support

This continuously updated library ensures providers and individuals have current educational tools at their fingertips. 

As a licensed healthcare provider, you can go deeper into the educational material at the Practitioner Education Hub. This hub requires login access, and is full of free educational materials created specifically for clinicians, including protocols, webinars, and more.

Frequently Asked Questions

Are there patient-friendly resources available on Cartigenix HP and joint health?*

Yes, the Cartigenix HP product information sheet is a great place to start. You can also provide individuals in your clinic with a handout comparing Cartigenix HP to glucosamine and chondriotin, a joint health and mobility tracker, research on Cartigenix HP, and access to our education center.

Is there a comparative handout for Cartigenix HP versus glucosamine or chondroitin?

Yes, this friendly handout quickly, easily compares Cartigenix HP to glucosamine and chondroitin in terms of outcomes, research, safety, and purity.

Is there a way to easily track joint health and mobility at home?

Yes, the Joint Health and Mobility Tracker is a great resource for individuals looking to track aspects of their joint health over a period of 90 days. It takes less than 10 minutes a week and is a great way to track progress between visits.

References

Desai DA, Shendge DP, Anand DS, Nair DS. Clinical effectiveness and tolerability of Celery seed and Boswellia serrata extract in osteoarthritis. Int J Orthop Sci. 2022;8(2):248-252. doi:10.22271/ortho.2022.v8.i2d.3143

Desai A, Anand S, Nair* S, Chorghe P. Assessing the effectiveness and NSAIDs sparing effect of celery seeds and Boswellia serrata in osteoarthritis management. Indian Journal of Orthopaedics Surgery. 2024;10(4). doi:10.18231/j.ijos.2024.052

Falvo D. Effective Patient Education: A Guide to Increased Adherence: . Jones & Bartlett Publishers; 2010.

Gold DT, McClung B. Approaches to Patient Education: Emphasizing the Long-Term Value of Compliance and Persistence. The American Journal of Medicine. 2006;119(4, Supplement 1):S32-S37. doi:10.1016/j.amjmed.2005.12.021

Lozada CJ. Glucosamine in osteoarthritis: Questions remain. CCJM. 2007;74(1):65-71.

Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795-808. doi:10.1056/NEJMoa052771

Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795-808. doi:10.1056/NEJMoa052771

Vaidya N, Agarwal R, Dipankar DG, et al. Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial. Pharm Res. Published online January 28, 2025. doi:10.1007/s11095-025-03818-2

Wandel S, Jüni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675. doi:10.1136/bmj.c4675

Zhu X, Sang L, Wu D, Rong J, Jiang L. Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2018;13(1):170. doi:10.1186/s13018-018-0871-5